JP2024512765A - トール様受容体アゴニストを使用したがん治療 - Google Patents
トール様受容体アゴニストを使用したがん治療 Download PDFInfo
- Publication number
- JP2024512765A JP2024512765A JP2023560819A JP2023560819A JP2024512765A JP 2024512765 A JP2024512765 A JP 2024512765A JP 2023560819 A JP2023560819 A JP 2023560819A JP 2023560819 A JP2023560819 A JP 2023560819A JP 2024512765 A JP2024512765 A JP 2024512765A
- Authority
- JP
- Japan
- Prior art keywords
- administered
- tlr9 agonist
- dose
- liver
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169674P | 2021-04-01 | 2021-04-01 | |
| US63/169,674 | 2021-04-01 | ||
| US202263298589P | 2022-01-11 | 2022-01-11 | |
| US63/298,589 | 2022-01-11 | ||
| PCT/US2022/022801 WO2022212690A1 (en) | 2021-04-01 | 2022-03-31 | Cancer therapy using toll-like receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512765A true JP2024512765A (ja) | 2024-03-19 |
| JP2024512765A5 JP2024512765A5 (cg-RX-API-DMAC7.html) | 2025-04-08 |
Family
ID=83456830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560819A Pending JP2024512765A (ja) | 2021-04-01 | 2022-03-31 | トール様受容体アゴニストを使用したがん治療 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4313315A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024512765A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240004419A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022249092A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3215582A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE112022001882T9 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022212690A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121568740A (zh) * | 2023-04-06 | 2026-02-24 | 特萨乐斯生命科学公司 | 用于提供局部湍流以递送医用栓塞剂的系统和装置 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210030783A1 (en) * | 2018-02-13 | 2021-02-04 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1364010B1 (en) | 2000-12-27 | 2010-06-16 | Dynavax Technologies Corporation | Immunomodulatory polynucleotides and methods of using the same |
| US20040009151A1 (en) * | 2002-04-04 | 2004-01-15 | Kay Mark A. | Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal |
| US8158768B2 (en) | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
| US7963956B2 (en) * | 2003-04-22 | 2011-06-21 | Antisense Pharma Gmbh | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
| US8500775B2 (en) | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
| US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
| US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
| US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
| HUE053145T2 (hu) * | 2014-12-31 | 2021-06-28 | Checkmate Pharmaceuticals Inc | Kombinált tumor immunterápia |
| US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
| EP3302501B1 (en) * | 2015-05-29 | 2021-09-22 | Merck Sharp & Dohme Corp. | Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating cancer |
| CA3020873A1 (en) * | 2016-04-15 | 2017-10-19 | Dynavax Technologies Corporation | Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancer |
| US10806893B2 (en) | 2017-01-10 | 2020-10-20 | Surefire Medical, Inc. | Guiding catheter having shape-retentive distal end |
| US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
| US20190298983A1 (en) | 2018-01-15 | 2019-10-03 | Surefire Medical, Inc. | Injection Port for Therapeutic Delivery |
| US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
| US12433597B2 (en) | 2019-06-04 | 2025-10-07 | Trisalus Life Sciences, Inc. | Atraumatic occlusive system with compartment for measurement of vascular pressure change |
| US20220249389A1 (en) * | 2019-07-12 | 2022-08-11 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| US12686870B2 (en) * | 2020-01-10 | 2026-07-21 | Sbi Biotech Co., Ltd. | TLR9 agonists |
| AU2021347154A1 (en) * | 2020-09-22 | 2023-05-11 | Trisalus Life Sciences, Inc. | Cancer therapy using toll-like receptor agonists |
-
2022
- 2022-03-31 AU AU2022249092A patent/AU2022249092A1/en active Pending
- 2022-03-31 CA CA3215582A patent/CA3215582A1/en active Pending
- 2022-03-31 WO PCT/US2022/022801 patent/WO2022212690A1/en not_active Ceased
- 2022-03-31 EP EP22782201.2A patent/EP4313315A4/en active Pending
- 2022-03-31 DE DE112022001882.8T patent/DE112022001882T9/de active Active
- 2022-03-31 JP JP2023560819A patent/JP2024512765A/ja active Pending
- 2022-03-31 KR KR1020237037584A patent/KR20240004419A/ko active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210030783A1 (en) * | 2018-02-13 | 2021-02-04 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
Non-Patent Citations (3)
| Title |
|---|
| CANCER DISCOVERY, vol. Volume 8, Issue 10, JPN6026016515, 2018, pages 1250 - 1257, ISSN: 0005856063 * |
| JOURNAL OF EXPERIMENTAL &CLINICAL CANCER RESEARCH, vol. Volume 40,Article 13, JPN6026016514, 6 January 2021 (2021-01-06), ISSN: 0005856062 * |
| ONCOLOGIC RESEARCH, vol. Volume 23, Issue 6, JPN6026016513, 2016, pages 321 - 326, ISSN: 0005856061 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3215582A1 (en) | 2022-10-06 |
| DE112022001882T9 (de) | 2024-02-29 |
| DE112022001882T5 (de) | 2024-01-18 |
| WO2022212690A1 (en) | 2022-10-06 |
| KR20240004419A (ko) | 2024-01-11 |
| AU2022249092A9 (en) | 2023-10-26 |
| AU2022249092A1 (en) | 2023-10-12 |
| EP4313315A1 (en) | 2024-02-07 |
| EP4313315A4 (en) | 2025-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3057990B1 (en) | Compositions comprising a combination of a vegf antagonist and an anti-ctla-4 antibody | |
| JP2023542988A (ja) | トール様受容体アゴニストを使用したがん治療 | |
| US20240180952A1 (en) | Cancer therapy using toll-like receptor agonists | |
| TWI451875B (zh) | 用於治療先前治療過之乳癌之抗-血管新生療法 | |
| KR20240004419A (ko) | 톨-유사 수용체 작용제를 사용한 암 요법 | |
| JP2023542989A (ja) | トール様受容体アゴニストを使用したがん治療 | |
| KR20230033647A (ko) | 난소암 백신에서 백혈병 유래 세포의 용도 | |
| HK40107087A (en) | Cancer therapy using toll-like receptor agonists | |
| CN116685330A (zh) | 使用toll样受体激动剂的癌症疗法 | |
| HK40100192A (en) | Cancer therapy using toll-like receptor agonists | |
| US20250101438A1 (en) | Methods of treating immune dysfunction in liver cancer with toll-like receptor agonists | |
| HK40096714A (en) | Cancer therapy using toll-like receptor agonists | |
| KR20200019229A (ko) | B형 간염 바이러스 감염을 특징으로 하는 간세포 암종의 치료 | |
| WO2025096686A1 (en) | Methods of treating pancreatic ductal adenocarcinoma with a toll-like receptor 9 agonist | |
| KR20240004703A (ko) | 체크포인트 저해제를 이용한 암 치료요법 | |
| HK40106247A (en) | Cancer therapy using checkpoint inhibitors | |
| JP2025507126A (ja) | 脂肪組織を画像化するための方法および材料 | |
| HK1227888A1 (en) | Compositions comprising a combination of a vegf antagonist and an anti-ctla-4 antibody |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250331 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250331 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260512 |